Axonics Inc

F:0I3 Germany
Market Cap
$3.33 Billion
€3.25 Billion EUR
Market Cap Rank
#3726 Global
#355 in Germany
Share Price
€63.50
Change (1 day)
+0.00%
52-Week Range
€63.50 - €63.50
All Time High
€76.50
About

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more

Axonics Inc (0I3) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: 0.026x

Based on the latest financial reports, Axonics Inc (0I3) has a cash flow conversion efficiency ratio of 0.026x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€16.98 Million) by net assets (€643.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Axonics Inc - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how Axonics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Axonics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Axonics Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Axonics Inc (2016–2023)

The table below shows the annual cash flow conversion efficiency of Axonics Inc from 2016 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 €637.56 Million €-2.02 Million -0.003x -156.50%
2022-12-31 €570.14 Million €3.19 Million 0.006x +105.71%
2021-12-31 €482.44 Million €-47.31 Million -0.098x +66.35%
2020-12-31 €287.37 Million €-83.74 Million -0.291x +36.10%
2019-12-31 €183.00 Million €-83.45 Million -0.456x -108.28%
2018-12-31 €143.28 Million €-31.37 Million -0.219x -180.02%
2017-12-31 €-66.42 Million €-18.18 Million 0.274x -21.97%
2016-12-31 €-49.43 Million €-17.34 Million 0.351x --